 1. Certain infectious and parasitic diseases (A00-B99)
|
|
2. Neoplasms (C00-D48)
|
|
 3. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
|
D50-D53 Nutritional anaemias
|
D55-D59 Haemolytic anaemias
|
D55 Anaemia due to enzyme disorders
|
 D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
D55.1 Anaemia due to other disorders of glutathione metabolism
D55.2 Anaemia due to disorders of glycolytic enzymes
D55.3 Anaemia due to disorders of nucleotide metabolism
D55.8 Other anaemias due to enzyme disorders
D55.9 Anaemia due to enzyme disorder, unspecified
|
D56 Thalassaemia
|
D57 Sickle-cell disorders
|
D58 Other hereditary haemolytic anaemias
|
D59 Acquired haemolytic anaemia
|
D60-D64 Aplastic and other anaemias
|
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
|
D70-D77 Other diseases of blood and blood-forming organs
|
D80-D89 Certain disorders involving the immune mechanism
|
|
4. Endocrine, nutritional and metabolic diseases (E00-E90)
|
E00-E07 Disorders of thyroid gland
|
E10-E14 Diabetes mellitus
|
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
|
E20-E35 Disorders of other endocrine glands
|
E40-E46 Malnutrition
|
E50-E64 Other nutritional deficiencies
|
E65-E68 Obesity and other hyperalimentation
|
E70-E90 Metabolic disorders
|
E70 Disorders of aromatic amino-acid metabolism
|
E70.0 Classical phenylketonuria
E70.1 Other hyperphenylalaninaemias
E70.2 Disorders of tyrosine metabolism
E70.3 Albinism
E70.8 Other disorders of aromatic amino-acid metabolism
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
|
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
|
E71.0 Maple-syrup-urine disease
E71.1 Other disorders of branched-chain amino-acid metabolism
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
E71.3 Disorders of fatty-acid metabolism
|
E72 Other disorders of amino-acid metabolism
|
E72.0 Disorders of amino-acid transport
E72.1 Disorders of sulfur-bearing amino-acid metabolism
E72.2 Disorders of urea cycle metabolism
E72.3 Disorders of lysine and hydroxylysine metabolism
E72.4 Disorders of ornithine metabolism
E72.5 Disorders of glycine metabolism
E72.8 Other specified disorders of amino-acid metabolism
E72.9 Disorder of amino-acid metabolism, unspecified
|
E73 Lactose intolerance
|
E74 Other disorders of carbohydrate metabolism
|
E74.0 Glycogen storage disease
E74.1 Disorders of fructose metabolism
E74.2 Disorders of galactose metabolism
E74.3 Other disorders of intestinal carbohydrate absorption
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
E74.8 Other specified disorders of carbohydrate metabolism
E74.9 Disorder of carbohydrate metabolism, unspecified
|
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
|
E75.0 GM2 gangliosidosis
E75.1 Other gangliosidosis
E75.2 Other sphingolipidosis
E75.3 Sphingolipidosis, unspecified
E75.4 Neuronal ceroid lipofuscinosis
E75.5 Other lipid storage disorders
E75.6 Lipid storage disorder, unspecified
|
E76 Disorders of glycosaminoglycan metabolism
|
E76.0 Mucopolysaccharidosis, type I
E76.1 Mucopolysaccharidosis, type II
E76.2 Other mucopolysaccharidoses
E76.3 Mucopolysaccharidosis, unspecified
E76.8 Other disorders of glucosaminoglycan metabolism
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
|
E77 Disorders of glycoprotein metabolism
|
E77.0 Defects in post-translational modification of lysosomal enzymes
E77.1 Defects in glycoprotein degradation
E77.8 Other disorders of glycoprotein metabolism
E77.9 Disorder of glycoprotein metabolism, unspecified
|
E78 Disorders of lipoprotein metabolism and other lipidaemias
|
E78.0 Pure hypercholesterolaemia
E78.1 Pure hyperglyceridaemia
E78.2 Mixed hyperlipidaemia
E78.3 Hyperchylomicronaemia
E78.4 Other hyperlipidaemia
E78.5 Hyperlipidaemia, unspecified
E78.6 Lipoprotein deficiency
E78.8 Other disorders of lipoprotein metabolism
E78.9 Disorder of lipoprotein metabolism, unspecified
|
E79 Disorders of purine and pyrimidine metabolism
|
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
E79.1 Lesch-Nyhan syndrome
E79.8 Other disorders of purine and pyrimidine metabolism
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
|
E80 Disorders of porphyrin and bilirubin metabolism
|
E80.0 Hereditary erythropoietic porphyria
E80.1 Porphyria cutanea tarda
E80.2 Other porphyria
E80.3 Defects of catalase and peroxidase
E80.4 Gilbert syndrome
E80.5 Crigler-Najjar syndrome
E80.6 Other disorders of bilirubin metabolism
E80.7 Disorder of bilirubin metabolism, unspecified
|
E83 Disorders of mineral metabolism
|
E83.0 Disorders of copper metabolism
E83.1 Disorders of iron metabolism
E83.2 Disorders of zinc metabolism
E83.3 Disorders of phosphorus metabolism and phosphatases
E83.4 Disorders of magnesium metabolism
E83.5 Disorders of calcium metabolism
E83.8 Other disorders of mineral metabolism
E83.9 Disorder of mineral metabolism, unspecified
|
E84 Cystic fibrosis
|
E85 Amyloidosis
|
E86 Volume depletion
|
E87 Other disorders of fluid, electrolyte and acid-base balance
|
E88 Other metabolic disorders
|
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
E88.1 Lipodystrophy, not elsewhere classified
E88.2 Lipomatosis, not elsewhere classified
E88.3 Tumour lysis syndrome
E88.8 Other specified metabolic disorders
E88.9 Metabolic disorder, unspecified
|
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
|
E90 Nutritional and metabolic disorders in diseases classified elsewhere
|
|
5. Mental and behavioural disorders (F00-F99)
|
|
6. Diseases of the nervous system (G00-G99)
|
|
7. Diseases of the eye and adnexa (H00-H59)
|
|
8. Diseases of the ear and mastoid process (H60-H95)
|
|
9. Diseases of the circulatory system (I00-I99)
|
|
10. Diseases of the respiratory system (J00-J99)
|
|
11. Diseases of the digestive system (K00-K93)
|
|
12. Diseases of the skin and subcutaneous tissue (L00-L99)
|
|
13. Diseases of the musculoskeletal system and connective tissue (M00-M99)
|
|
14. Diseases of the genitourinary system (N00-N99)
|
|
15. Pregnancy, childbirth and the puerperium (O00-O99)
|
|
16. Certain conditions originating in the perinatal period (P00-P96)
|
P00-P04 Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
|
P05-P08 Disorders related to length of gestation and fetal growth
|
P10-P15 Birth trauma
|
P20-P29 Respiratory and cardiovascular disorders specific to the perinatal period
|
P35-P39 Infections specific to the perinatal period
|
P50-P61 Haemorrhagic and haematological disorders of fetus and newborn
|
P70-P74 Transitory endocrine and metabolic disorders specific to fetus and newborn
|
P70 Transitory disorders of carbohydrate metabolism specific to fetus and newborn
|
P70.0 Syndrome of infant of mother with gestational diabetes
P70.1 Syndrome of infant of a diabetic mother
P70.2 Neonatal diabetes mellitus
P70.3 Iatrogenic neonatal hypoglycaemia
P70.4 Other neonatal hypoglycaemia
P70.8 Other transitory disorders of carbohydrate metabolism of fetus and newborn
P70.9 Transitory disorder of carbohydrate metabolism of fetus and newborn, unspecified
|
P71 Transitory neonatal disorders of calcium and magnesium metabolism
|
P71.0 Cow milk hypocalcaemia in newborn
P71.1 Other neonatal hypocalcaemia
P71.2 Neonatal hypomagnesaemia
P71.3 Neonatal tetany without calcium or magnesium deficiency
P71.4 Transitory neonatal hypoparathyroidism
P71.8 Other transitory neonatal disorders of calcium and magnesium metabolism
P71.9 Transitory neonatal disorder of calcium and magnesium metabolism, unspecified
|
P72 Other transitory neonatal endocrine disorders
|
P74 Other transitory neonatal electrolyte and metabolic disturbances
|
P75-P78 Digestive system disorders of fetus and newborn
|
P80-P83 Conditions involving the integument and temperature regulation of fetus and newborn
|
P90-P96 Other disorders originating in the perinatal period
|
|
17. Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
|
|
18. Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
|
|
19. Injury, poisoning and certain other consequences of external causes (S00-T98)
|
S00-S09 Injuries to the head
|
S10-S19 Injuries to the neck
|
S20-S29 Injuries to the thorax
|
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis
|
S40-S49 Injuries to the shoulder and upper arm
|
S50-S59 Injuries to the elbow and forearm
|
S60-S69 Injuries to the wrist and hand
|
S70-S79 Injuries to the hip and thigh
|
S80-S89 Injuries to the knee and lower leg
|
S90-S99 Injuries to the ankle and foot
|
T00-T07 Injuries involving multiple body regions
|
T08-T14 Injuries to unspecified part of trunk, limb or body region
|
T15-T19 Effects of foreign body entering through natural orifice
|
T20-T25 Burns and corrosions of external body surface, specified by site
|
T26-T28 Burns and corrosions confined to eye and internal organs
|
T29-T32 Burns and corrosions of multiple and unspecified body regions
|
T33-T35 Frostbite
|
T36-T50 Poisoning by drugs, medicaments and biological substances
|
T36 Poisoning by systemic antibiotics
|
T37 Poisoning by other systemic anti-infectives and antiparasitics
|
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
|
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
|
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
|
T41 Poisoning by anaesthetics and therapeutic gases
|
T42 Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugs
|
T43 Poisoning by psychotropic drugs, not elsewhere classified
|
T44 Poisoning by drugs primarily affecting the autonomic nervous system
|
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
|
T46 Poisoning by agents primarily affecting the cardiovascular system
|
T47 Poisoning by agents primarily affecting the gastrointestinal system
|
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
|
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs
|
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
|
T50.0 Poisoning: Mineralocorticoids and their antagonists
T50.1 Poisoning: Loop [high-ceiling] diuretics
T50.2 Poisoning: Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
T50.3 Poisoning: Electrolytic, caloric and water-balance agents
T50.4 Poisoning: Drugs affecting uric acid metabolism
T50.5 Poisoning: Appetite depressants
T50.6 Poisoning: Antidotes and chelating agents, not elsewhere classified
T50.7 Poisoning: Analeptics and opioid receptor antagonists
T50.8 Poisoning: Diagnostic agents
T50.9 Poisoning: Other and unspecified drugs, medicaments and biological substances
|
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
|
T66-T78 Other and unspecified effects of external causes
|
T79-T79 Certain early complications of trauma
|
T80-T88 Complications of surgical and medical care, not elsewhere classified
|
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
|
|
20. External causes of morbidity and mortality (V01-Y98)
|
V01-V09 Pedestrian injured in transport accident
|
V10-V19 Pedal cyclist injured in transport accident
|
V20-V29 Motorcycle rider injured in transport accident
|
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
|
V40-V49 Car occupant injured in transport accident
|
V50-V59 Occupant of pick-up truck or van injured in transport accident
|
V60-V69 Occupant of heavy transport vehicle injured in transport accident
|
V70-V79 Bus occupant injured in transport accident
|
V80-V89 Other land transport accidents
|
V90-V94 Water transport accidents
|
V95-V97 Air and space transport accidents
|
V98-V99 Other and unspecified transport accidents
|
W00-W19 Falls
|
W20-W49 Exposure to inanimate mechanical forces
|
W50-W64 Exposure to animate mechanical forces
|
W65-W74 Accidental drowning and submersion
|
W75-W84 Other accidental threats to breathing
|
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
|
X00-X09 Exposure to smoke, fire and flames
|
X10-X19 Contact with heat and hot substances
|
X20-X29 Contact with venomous animals and plants
|
X30-X39 Exposure to forces of nature
|
X40-X49 Accidental poisoning by and exposure to noxious substances
|
X50-X57 Overexertion, travel and privation
|
X58-X59 Accidental exposure to other and unspecified factors
|
X60-X84 Intentional self-harm
|
X85-Y09 Assault
|
Y10-Y34 Event of undetermined intent
|
Y35-Y36 Legal intervention and operations of war
|
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
|
Y40 Systemic antibiotics
|
Y41 Other systemic anti-infectives and antiparasitics
|
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
|
Y43 Primarily systemic agents
|
Y44 Agents primarily affecting blood constituents
|
Y45 Analgesics, antipyretics and anti-inflammatory drugs
|
Y46 Antiepileptics and antiparkinsonism drugs
|
Y47 Sedatives, hypnotics and antianxiety drugs
|
Y48 Anaesthetics and therapeutic gases
|
Y49 Psychotropic drugs, not elsewhere classified
|
Y50 Central nervous system stimulants, not elsewhere classified
|
Y51 Drugs primarily affecting the autonomic nervous system
|
Y52 Agents primarily affecting the cardiovascular system
|
Y53 Agents primarily affecting the gastrointestinal system
|
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
|
Y54.0 Mineralocorticoids
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
Y54.2 Carbonic-anhydrase inhibitors
Y54.3 Benzothiadiazine derivatives
Y54.4 Loop [high-ceiling] diuretics
Y54.5 Other diuretics
Y54.6 Electrolytic, caloric and water-balance agents
Y54.7 Agents affecting calcification
Y54.8 Agents affecting uric acid metabolism
Y54.9 Mineral salts, not elsewhere classified
|
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
|
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
|
Y57 Other and unspecified drugs and medicaments
|
Y58 Bacterial vaccines
|
Y59 Other and unspecified vaccines and biological substances
|
Y60-Y69 Misadventures to patients during surgical and medical care
|
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
|
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
|
Y85-Y89 Sequelae of external causes of morbidity and mortality
|
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
|
|
21. Factors influencing health status and contact with health services (Z00-Z99)
|
|
22. Codes for special purposes (U00-U85)
|
ICD-10 International Classification of Diseases